• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沉默 Sorcin 抑制上皮间质转化并抑制体内乳腺癌转移。

Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.

机构信息

State Key Laboratory of Experimental Hematology, Department of Pharmacy, Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.

出版信息

Breast Cancer Res Treat. 2014 Jan;143(2):287-99. doi: 10.1007/s10549-013-2809-2. Epub 2013 Dec 15.

DOI:10.1007/s10549-013-2809-2
PMID:24337682
Abstract

Sorcin, a 22-kDa calcium-binding protein, renders cancer cells resistant to chemotherapeutic agents, thus playing an important role in multidrug resistance. As there is a clear association between drug resistance and an aggressive phenotype, we asked whether sorcin affects also the motility, invasion, and stem cell characteristics of cancer cells. We have used both RNA interference (transient and stable expression of hairpins) and a lentiviral expression vector to experimentally modulate sorcin expression in a variety of cells. We demonstrate that sorcin depletion in MDA-MB-231 breast cancer cells reduces the pool of CD44(+)/CD24(-) and ALDH1(high) cancer stem cells (CSCs) as well as mammosphere-forming capacity. We also observe that sorcin regulates epithelial-mesenchymal transition and CSCs partly through E-cadherin and vascular endothelial growth factor expression. This leads to the acquisition of an epithelial-like phenotype, attenuating epithelial-mesenchymal transition and suppression of metastases in nude mice. The sorcin-depleted phenotype can also be reproduced in lung adenocarcinoma A549 cells and lung fibrosarcoma HT1080 cells. In addition, overexpression of sorcin in MCF7 cells, which have low endogenous sorcin expression levels, increases their migration and invasion in vitro. This offers the rationale for the development of therapeutic strategies down-regulating sorcin expression for the treatment of cancer.

摘要

钙结合蛋白 22kDa(Sorcin)可使癌细胞对化疗药物产生耐药性,从而在多药耐药中发挥重要作用。由于耐药性与侵袭性表型之间存在明确的关联,我们想知道 Sorcin 是否也会影响癌细胞的迁移、侵袭和干细胞特性。我们使用 RNA 干扰(发夹的瞬时和稳定表达)和慢病毒表达载体在多种细胞中实验性地调节 Sorcin 的表达。我们证明,在 MDA-MB-231 乳腺癌细胞中敲低 Sorcin 会减少 CD44(+)/CD24(-) 和 ALDH1(high) 肿瘤干细胞 (CSC) 以及乳腺球体形成能力。我们还观察到 Sorcin 通过 E-钙黏蛋白和血管内皮生长因子的表达部分调节上皮-间充质转化和 CSCs。这导致获得上皮样表型,减弱上皮-间充质转化并抑制裸鼠中的转移。在肺腺癌 A549 细胞和肺纤维肉瘤 HT1080 细胞中也可以再现 Sorcin 耗竭表型。此外,在 MCF7 细胞中过表达 Sorcin(其内源 Sorcin 表达水平较低)可增加其体外迁移和侵袭能力。这为开发下调 Sorcin 表达的治疗策略提供了治疗癌症的理论依据。

相似文献

1
Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.沉默 Sorcin 抑制上皮间质转化并抑制体内乳腺癌转移。
Breast Cancer Res Treat. 2014 Jan;143(2):287-99. doi: 10.1007/s10549-013-2809-2. Epub 2013 Dec 15.
2
MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.miR-21 调控第三球体形成乳腺癌干细胞样细胞中的上皮-间充质转化表型和低氧诱导因子-1α 的表达。
Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.
3
Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.miR-21 的重新表达通过诱导上皮-间充质转化,促进 MCF-7 细胞的迁移和侵袭,与癌症干细胞特征一致。
Mol Cell Biochem. 2012 Apr;363(1-2):427-36. doi: 10.1007/s11010-011-1195-5. Epub 2011 Dec 21.
4
Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.抑制sorcin 通过调节凋亡相关蛋白逆转 K562/A02 细胞和 MCF-7/A02 细胞的多药耐药性。
Cancer Chemother Pharmacol. 2013 Oct;72(4):789-98. doi: 10.1007/s00280-013-2254-2. Epub 2013 Sep 8.
5
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.尼卡斯特林和Notch4驱动MCF7乳腺癌细胞的内分泌治疗耐药性及上皮-间质转化。
Breast Cancer Res. 2014 Jun 11;16(3):R62. doi: 10.1186/bcr3675.
6
ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.ALDH1 表达与肺腺癌的上皮样表型和良好预后相关:基于免疫组织化学和 mRNA 表达数据的研究。
J Cancer Res Clin Oncol. 2019 Jun;145(6):1427-1436. doi: 10.1007/s00432-019-02906-2. Epub 2019 Mar 28.
7
Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.磷脂酰肌醇蛋白聚糖-3可诱导人乳腺癌细胞发生间充质向上皮转化。
Oncotarget. 2016 Sep 13;7(37):60133-60154. doi: 10.18632/oncotarget.11107.
8
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.PARP3通过刺激转谷氨酰胺酶2-蜗牛-E-钙黏蛋白轴来控制转化生长因子β和活性氧驱动的上皮-间质转化及干性。
Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.
9
Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.染色质蛋白激酶 C-θ 直接调节上皮间质转化和乳腺癌干细胞中的诱导基因。
Mol Cell Biol. 2014 Aug;34(16):2961-80. doi: 10.1128/MCB.01693-13. Epub 2014 Jun 2.
10
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.转化生长因子-β(TGF-β)与紫杉醇联合抑制上皮-间质转化和乳腺癌干细胞样细胞。
Oncotarget. 2015 Nov 10;6(35):37526-43. doi: 10.18632/oncotarget.6063.

引用本文的文献

1
Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeutics.索辛蛋白:在癌症特征、耐药性及治疗机遇方面的作用机制
Med Oncol. 2024 Dec 14;42(1):29. doi: 10.1007/s12032-024-02580-6.
2
Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.索辛在癌症发展和化疗耐药中的作用
Cancers (Basel). 2024 Aug 9;16(16):2810. doi: 10.3390/cancers16162810.
3
Sorcin regulate pyroptosis by interacting with NLRP3 inflammasomes to facilitate the progression of hepatocellular carcinoma.Sorcin 通过与 NLRP3 炎性小体相互作用调节细胞焦亡,促进肝癌的进展。
Cell Death Dis. 2023 Oct 13;14(10):678. doi: 10.1038/s41419-023-06096-1.
4
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways.Sorcin 促进癌症迁移并调节 EGF 依赖性 EGFR 信号通路。
Cell Mol Life Sci. 2023 Jul 13;80(8):202. doi: 10.1007/s00018-023-04850-4.
5
Tissue proteome analysis for profiling proteins associated with lymph node metastasis in gallbladder cancer.组织蛋白质组分析用于分析与胆囊癌淋巴结转移相关的蛋白质谱。
BMC Cancer. 2023 May 4;23(1):402. doi: 10.1186/s12885-023-10840-3.
6
Multi-Omics Analysis of Glioblastoma and Glioblastoma Cell Line: Molecular Insights Into the Functional Role of GPR56 and TG2 in Mesenchymal Transition.胶质母细胞瘤和胶质母细胞瘤细胞系的多组学分析:对GPR56和TG2在间充质转化中功能作用的分子见解
Front Oncol. 2022 May 3;12:841890. doi: 10.3389/fonc.2022.841890. eCollection 2022.
7
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.抗微管蛋白药物的耐药性:从长春花生物碱到埃坡霉素
Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019.
8
Clinical Significance and Prognostic Value of Human Soluble Resistance-Related Calcium-Binding Protein: A Pan-Cancer Analysis.人可溶性抗性相关钙结合蛋白的临床意义及预后价值:一项泛癌分析
Front Med (Lausanne). 2021 Nov 16;8:752619. doi: 10.3389/fmed.2021.752619. eCollection 2021.
9
Sorcin Activates the Brain PMCA and Blocks the Inhibitory Effects of Molecular Markers of Alzheimer's Disease on the Pump Activity.索辛激活大脑 PMCA 并阻断阿尔茨海默病分子标志物对泵活性的抑制作用。
Int J Mol Sci. 2021 Jun 3;22(11):6055. doi: 10.3390/ijms22116055.
10
A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.一种新型的 Sorcin 内稳态循环通过 Smad4/ZEB1/miR-142-5p 驱动紫杉醇耐药和人类卵巢癌的恶性进展。
Oncogene. 2021 Jul;40(30):4906-4918. doi: 10.1038/s41388-021-01891-6. Epub 2021 Jun 23.